P-Predict is an application that predicts the effects of various doses of radiotherapy (RT) and durations of androgen deprivation therapy (ADT) on patients receiving definitive RT for prostate cancer.
P-Predict estimates the probability of biochemical failure (BF) at 8 years after RT, taking into account palpation T-category, biopsy Gleason score, the percentage of tumor cells with a Gleason pattern of 4 or 5, the percentage of tumor tissue, initial pretreatment prostate-specific antigen (PSA) level, ADT duration, and RT dose.
P-Predict estimates the probability of biochemical failure (BF) at 8 years after RT, taking into account palpation T-category, biopsy Gleason score, the percentage of tumor cells with a Gleason pattern of 4 or 5, the percentage of tumor tissue, initial pretreatment prostate-specific antigen (PSA) level, ADT duration, and RT dose.
Show More
